Reproducibility and Method Comparison Studies of the Quo-Test™ A1C System and the Quo-Lab A1C Test and CLIA Waiver Study of the Quo-Test™ A1C System
Status: | Terminated |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/21/2016 |
Start Date: | April 2013 |
End Date: | April 2014 |
Reproducibility and Method Comparison of the Quo-Test™ A1C System and the Quo-Lab A1C Test and CLIA Waiver of the Quo-Test™ A1C System
The Quo-Test A1C Analyzer and Reagent Test System (Quo-Test A1C System) are intended for the
in-vitro quantitative determination of glycated hemoglobin in whole blood samples obtained
from fingerstick or venous samples for point-of-care testing. The Quo-Test A1C System is
indicated in the management and treatment of diabetes and for monitoring long term glycemic
control by diabetics. It is for multiple patient use. Only auto-disabling, single use
lancing devices should be used with this system.
in-vitro quantitative determination of glycated hemoglobin in whole blood samples obtained
from fingerstick or venous samples for point-of-care testing. The Quo-Test A1C System is
indicated in the management and treatment of diabetes and for monitoring long term glycemic
control by diabetics. It is for multiple patient use. Only auto-disabling, single use
lancing devices should be used with this system.
Inclusion Criteria:
- Aged 18 years or over
- Able to read English
- Read, understood and signed the Informed Consent Form
- Agrees to participate and does not withdraw\
- Either healthy (without diabetes) or has Type 1 or Type 2 diabetes
Exlcusion Criteria:
• Declines participation or withdraws before study completion
We found this trial at
3
sites
University of Missouri T he University of Missouri was founded in 1839 in Columbia, Mo.,...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials